Key facts
- Brain4care’s last known valuation is $49.3M (Jun 2023).
- It has raised $33.3M; the latest was Later Stage VC ($2.0M) in Dec 2025.
- Notable investors include GHT4 Group, Carlos Gutiérrez, Green Rock (Brazil), Horácio Lafer Piva, Miletus Ventures — 6 tracked in total.
- Status: Privately Held (backing).
- ·The complete investor list — 6 names
- ·Watchlist + deal alerts for Brain4care
- ·The full record, as it builds
Funding rounds
No funding rounds for Brain4care are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About Brain4care
Developer of a non-invasive neurotechnology platform intended to monitor intracranial dynamics through cranial pulse analysis. The company offers an AI (artificial intelligence)-powered system for assessing brain compliance, pressure, perfusion, and autoregulation without invasive procedures, enabling healthcare providers to detect neurological deterioration earlier and improve patient monitoring outcomes.
- Sector
- Healthcare
- HQ
- Sao Carlos, Brazil
- Founded
- 2014
- Employees
- 40
- Website
- brain4.care/
- Ownership
- Privately Held (backing)
Brain4care doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in Brain4care shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on Brain4care in its N-PORT filings yet. We sweep new filings monthly.